Liang Zheng

1 article listing Liang Zheng in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Tislelizumab plus lenvatinib in advanced fumarate hydratase-deficient renal cell carcinoma: a single-arm, phase 2 trial with metabolic biomarker analysis Nature Communications